Status:
UNKNOWN
Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication
Lead Sponsor:
University College Dublin
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether exercise is beneficial for people with rheumatoid arthritis(RA) taking antiTNFalpha medication
Detailed Description
Substantial progress has been made in the medical management of RA over the past decade but at present no drug therapy leads to long-term remission for all patients with RA. People may still continue ...
Eligibility Criteria
Inclusion
- Patients with RA receiving anti-TNFalpha therapy medication for more than three months
- Consenting male and female patients aged 18 - 70 years
- Patients will have a documented diagnosis of RA as classified by the American College of Rheumatology (ACR) criteria
- ACR functional class I, II, III
Exclusion
- Patients who have attended physiotherapy in the past three months
- Patients to whom exercise therapy or hydrotherapy are contraindicated
- Patients who have undergone joint surgery in the past six months
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00855322
Start Date
January 1 2008
End Date
July 1 2009
Last Update
March 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Our Lady's Hospice
Dublin, Dublin, Ireland, 6W